Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?

Volume: 40, Issue: 3, Pages: 256 - 259
Published: Jun 1, 2017
Abstract
PURPOSE The FDA approved C-11 choline PET/computed tomography (CT) for imaging patients with recurrent prostate cancer in 2012. Subsequently, the 2014 NCCN guidelines have introduced labeled choline PET/CT in the imaging algorithm of patients with suspected recurrent disease. However, there is only scarce data on the impact of labeled choline PET/CT findings on disease management. We hypothesized that labeled-choline PET/CT studies showing local...
Paper Details
Title
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Published Date
Jun 1, 2017
Volume
40
Issue
3
Pages
256 - 259
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.